Recall StatusOpen, Classified
Date Initiated2025-08-19
Product Quantity1,980,000
Reason for Recall
Some of the Vacuette CAT Serum Separator Clot Activator tubes were manufactured without gel separator, which could yield erroneous assay results and require the patient to return to the lab for recollection or repeat testing. This may result in delayed diagnosis, cause a delay in clinical decision-making or treatment and in some rare cases, yield incorrect results from less stable parameters.
Firm Action
On 08/22/2025, the firm sent via email an "Urgent Medical Device Correction" letter to customer informing them that some Vacuette CAT Serum Separator Clot Activator tubes were manufactured without gel separator which may affect the stability of the sample.
Customers are instructed to:
" Stop use immediately: Discontinue use of the affected product (concerned Item/Lot)
and isolate it within your facility.
" Notify staff and customers: Inform all relevant employees and notify all customers to
whom you distributed the affected products.
" Assess risk: Evaluate potential risks or consequences in accordance with your internal
procedures and take appropriate action.
" Confirm product disposition: Complete the attached Product Disposition Site
Confirmation Form and return it via fax to 877-217-7927 or email to
[email protected].
Confirmation is required that all affected products have been discarded/destroyed.
Replacement products will be provided upon receipt of your completed form.
For questions, call Greiner Bio-One Technical Service at 800-515-8112.
Root Cause
Labeling Change Control
Distribution Pattern
U.S.: AL, AR, CA, CO, CT, FL, GA, IA, IL, IN, KS, LA, MA, MD, ME, MI, MO, MS, NJ, NY, OH, OK, PA, TN, TX, UT, VA and WY.
O.U.S.: None
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.